Search results

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020

Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults

Type

Highly specialised technologies guidance

Published

24 February 2021

Evidence-based recommendations on cyanoacrylate glue occlusion for varicose veins. This involves injecting medical glue (cyanoacrylate) into a vein to close it

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy in adults and children. This involves inserting a

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on selective internal radiation therapy for unresectable colorectal metastases in the liver in adults. This involves injecting

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on artificial iris insertion for acquired aniridia. This involves inserting an artificial iris into the eye

Type

Interventional procedures guidance

Published

22 July 2020

Evidence-based recommendations on artificial iris insertion for congenital aniridia. This involves inserting an artificial iris into the eye

Type

Interventional procedures guidance

Published

22 July 2020

Evidence-based recommendations on transcranial magnetic stimulation for auditory hallucinations. This involves stimulating the brain with pulses of

Type

Interventional procedures guidance

Published

23 September 2020

Evidence-based recommendations on intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention in adults. This involves

Type

Interventional procedures guidance

Published

24 June 2020

Evidence-based recommendations on deep brain stimulation for refractory epilepsy in adults. This involves implanting an electrical stimulator in the brain

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on vagus nerve stimulation for treatment-resistant depression in adults. This involves implanting an electrical stimulator under

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on transcranial magnetic stimulation for obsessive-compulsive disorder in adults. This involves pulsing electromagnetic energy

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse in adults

Type

Interventional procedures guidance

Published

04 March 2020

Evidence-based recommendations on swallowable gastric balloon capsules for weight loss in adults. This involves swallowing a capsule containing a balloon that

Type

Interventional procedures guidance

Published

18 November 2020

Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for Barrett’s oesophagus. This involves using a balloon filled with cold gas to destroy abnormal cells

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for squamous dysplasia of the oesophagus. This involves using a balloon filled with cold gas to destroy

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on self-expanding implant insertion into the intersphincteric space for faecal incontinence. This involves inserting implants

Type

Interventional procedures guidance

Published

27 January 2021

Evidence-based recommendations on minimally invasive radical hysterectomy for early stage cervical cancer. This involves removing the uterus, cervix, upper

Type

Interventional procedures guidance

Published

27 January 2021

Evidence-based recommendations on mepolizumab (Nucala) for treating severe eosinophilic asthma in adults

Type

Technology appraisal guidance

Published

03 February 2021

Evidence-based recommendations on brolucizumab (Beovu) for treating wet age-related macular degeneration in adults

Type

Technology appraisal guidance

Published

03 February 2021

Evidence-based recommendations on carfilzomib (Kyprolis) for previously treated multiple myeloma in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on nivolumab (Opdivo) for advanced squamous non-small-cell lung cancer in adults after chemotherapy

Type

Technology appraisal guidance

Published

21 October 2020

Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive

Type

Technology appraisal guidance

Published

14 October 2020

NICE is unable to make a recommendation on alpelisib (Piqray) with fulvestrant for treating hormone-receptor positive, HER2-negative, PIK3CA-positive advanced

Type

Technology appraisal guidance

Published

07 October 2020

Evidence-based recommendations on naldemedine (Rizmoic) for treating opioid-induced constipation in adults who have had laxative treatment

Type

Technology appraisal guidance

Published

30 September 2020

Evidence-based recommendations on pembrolizumab (Keytruda) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults

Type

Technology appraisal guidance

Published

30 September 2020

NICE is unable to make a recommendation on dupilumab (Dupixent) for treating chronic rhinosinusitis with nasal polyps because Sanofi did not provide an evidence

Type

Technology appraisal guidance

Published

09 September 2020

Evidence-based recommendations on avelumab (Bavencio) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults

Type

Technology appraisal guidance

Published

02 September 2020

Evidence-based recommendations on encorafenib (Braftovi) plus cetuximab (Erbitux) for treating BRAF V600E mutation-positive metastatic colorectal cancer in

Type

Technology appraisal guidance

Published

06 January 2021

Evidence-based recommendations on caplacizumab (Cablivi) with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic

Type

Technology appraisal guidance

Published

16 December 2020

Evidence-based recommendations on darolutamide (Nubeqa) for treating hormone-relapsed prostate cancer in adults at high risk of developing metastatic disease

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on using coronary artery stents in adults

Type

Technology appraisal guidance

Last updated

18 November 2020

Evidence-based recommendations on trabectedin (Yondelis) for treating advanced soft tissue sarcoma (tumours/cancer)

Type

Technology appraisal guidance

Last updated

08 February 2021

Evidence-based recommendations on galcanezumab (Emgality) for preventing migraine in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on pembrolizumab (Keytruda) for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) in a

Type

Technology appraisal guidance

Published

25 November 2020

NICE is unable to make a recommendation on durvalumab (Imfinzi) in combination for untreated extensive-stage small-cell lung cancer in adults because AstraZenec

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on venetoclax (Venclyxto) with obinutuzumab for untreated chronic lymphocytic leukaemia in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on upadacitinib (Rinvoq) for severe active rheumatoid arthritis in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on larotrectinib (Vitrakvi) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and

Type

Technology appraisal guidance

Published

27 May 2020

Evidence-based recommendations on fremanezumab (Ajovy) for preventing chronic migraine in adults

Type

Technology appraisal guidance

Published

03 June 2020

Evidence-based recommendations on ustekinumab (Stelara) for treating moderately to severely active ulcerative colitis in adults

Type

Technology appraisal guidance

Published

17 June 2020

NICE is unable to make a recommendation on daratumumab (Darzalex) with lenalidomide and dexamethasone for untreated multiple myeloma, because Janssen did not

Type

Technology appraisal guidance

Published

30 June 2020

NICE is unable to make a recommendation on ramucirumab (Cyramza) with erlotinib for untreated epidermal growth factor receptor (EGFR)-positive metastatic non

Type

Technology appraisal guidance

Published

30 June 2020

NICE is unable to make a recommendation on eculizumab (Soliris) for treating refractory myasthenia gravis because Alexion Pharma UK did not provide an evidence

Type

Technology appraisal guidance

Published

30 June 2020

NICE is unable to make a recommendation about the use in the NHS of ranibizumab (Lucentis) for treating diabetic retinopathy because Novartis did not provide an

Type

Technology appraisal guidance

Published

30 June 2020

Evidence-based recommendations on atezolizumab (Tecentriq) for untreated extensive-stage small-cell lung cancer in adults

Type

Technology appraisal guidance

Published

01 July 2020

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults

Type

Technology appraisal guidance

Published

16 December 2020